In 1901, Karl Landsteiner, a Viennese MD and pathologist, discovered ABO blood group system which was the first human blood group[@b1]. From then on, studies on relation of ABO blood group system to various diseases have never been interrupted for a century, even in the popular era of gene detection, as ABO blood group is inherent in human's body and easily to be tested.

It has been reported that ABO blood group system is associated with cognitive impairment[@b2], preeclampsia[@b3], bleeding, neoplastic diseases[@b4], and even longevity[@b5]. Among all of those studies, the mechanism of relationship between ABO blood group and venous thrombosis is elucidated[@b6], and its major determinants are von Willebrand factor (vWF) and coagulation factor VIII[@b7] which result in thrombosis. This interesting finding makes a theoretical hypothesis that ABO blood group may also be related to risk of coronary artery disease (CAD) and myocardial infarction (MI). Unfortunately, results of previous relevant studies are currently not convincing due to inconsistent conclusions. And previous studies including original observations and meta-analysis[@b8][@b9][@b10] mainly paid attention to the blood group non-O and O, ignoring the blood group A and other blood types. Moreover, in those studies, links of ABO blood group with MI was often focused on; however, the relation between risk of CAD and ABO blood group was carelessly overlooked. Therefore, this updated systematic review and meta-analysis aims to evaluate the relationship between CAD and each type of ABO blood group.

Results {#sec2}
=======

Description of included studies
-------------------------------

Two hundred and thirty-one studies (231 from Pubmed and 0 from the Cochrane Library) were identified from two databases. Among them, 10 records were removed on account of duplicates. By screening titles and abstracts, we excluded 147 records on account of animal experiments, traditional reviews, improper or lack of comparison, or other blood group classification systems rather than ABO blood type. By browsing full-text articles, we excluded 58 records because of improper or lack of comparison, other confounding factors, irrelevant to the outcomes of this study and unavailable outcomes. At last, a total of 16 articles[@b11][@b12][@b13][@b14][@b15][@b16][@b17][@b18][@b19][@b20][@b21][@b22][@b23][@b24][@b25][@b26] which met inclusion criteria were included into this systematic review. A flow-chart of study selection was generated according to the PRISMA requirements ([Fig. 1](#f1){ref-type="fig"}).

Study characteristics
---------------------

One[@b15] of these 16 articles contained 2 studies. All the 17 studies were published in English from 1961 to 2014. Eleven articles[@b11][@b13][@b14][@b16][@b17][@b19][@b21][@b22][@b23][@b25][@b26] were case-control studies, 2 articles[@b12][@b15] were prospective cohort studies and 3 articles[@b18][@b20][@b24] were retrospective cohort studies. Finally, a total of 225,810 patients were included. All studies described race and characteristic of the two groups. Nine studies[@b12][@b16][@b17][@b19][@b20][@b21][@b22][@b23][@b24] merely mentioned MI. Two studies[@b12][@b17] only differentiated blood group non-O from blood group O. The remaining studies described all blood types. (Basic characteristics of included studies were presented in [Table 1](#t1){ref-type="table"} and blood types distribution and outcome definitions of included studies were presented in [Table 2](#t2){ref-type="table"}, and Newcastle-Ottawa Scale (NOS) table was shown in [Table 3](#t3){ref-type="table"}).

Main, subgroup and sensitivity analysis
---------------------------------------

All the 17 studies were included in this meta-analysis. Because of unnegligible heterogeneity in them, we conducted a subgroup analysis according to the research types (case-control study, prospective or retrospective cohort study) and used random-effect model[@b27]. Risk of CAD was significantly increased in patients with blood group A compared with blood group non-A (odds ratio (OR) = 1.14, 95% confidence intervals (CI) = 1.03 to 1.26, p = 0.01). Subjects in blood group A had a statistical increase in CAD incidence in case-control studies (OR = 1.14, 95% CI = 1.04 to 1.26, p = 0.005) with moderate heterogeneity (I^2^ = 45%), while there was no statistical difference between blood group A and non-A in cohort studies ([Fig. 2](#f2){ref-type="fig"}). Besides, risk of CAD had no statistical significant difference in patients with blood group B, AB compared with non-B, non-AB, respectively ([Figs 3](#f3){ref-type="fig"} and [4](#f4){ref-type="fig"}). Whereas, in contrast to the result of blood group A, blood group O was proved to be a protective factor in our analysis, presenting a decrease of CAD risk (OR = 0.85, 95% CI = 0.78 to 0.94, p = 0.0008). Our analysis found that there was statistical significant difference in CAD incidence in case-control studies (OR = 0.86, 95% CI = 0.75 to 0.99, p = 0.04) in spite of high heterogeneity (I^2^ = 78%), which is similar to prospective cohort studies (OR = 0.94, 95% CI = 0.89 to 0.98, p = 0.009) with no heterogeneity (I^2^ = 0). However, there was no statistical significant difference in CAD incidence in retrospective cohort studies (OR = 0.58, 95% CI = 0.35 to 0.97, p = 0.04) with high heterogeneity (I^2^ = 70%) ([Fig. 5](#f5){ref-type="fig"}). In the sensitivity analysis, exclusion of any single study did not substantively alter the overall result in blood group A, B, AB and O. In order to exclude the effect of established positive relationship between ABO blood group and MI, we removed the studies[@b12][@b16][@b17][@b19][@b20][@b21][@b22][@b23][@b24] which only paid attention to MI patients and found the similar relationship between ABO blood group and CAD as before, namely, A (OR = 1.05, 95% CI = 1.00 to 1.10, p = 0.03) and O (OR = 0.89, 95% CI = 0.85 to 0.93, p \< 0.00001).

Furthermore, risk of MI was significantly higher in blood group A (OR = 1.24, 95% CI = 0.97 to 1.59, p = 0.08) compared with non-A group. Nevertheless, patients with blood group B or AB compared to non-B or non-AB, respectively, had no statistical differences in MI incidence (OR = 0.94, 95% CI = 0.74 to 1.18, p = 0.59; OR = 1.11, 95% CI = 0.91 to 1.35, P = 0.31). However, an overall effect was detected to be statistically different when comparing blood group O with non-O for the risk of MI (OR = 0.81, 95% CI = 0.69 to 0.94, p = 0.007).

Publication bias
----------------

We generated a funnel plot to assess publication bias. Exploration for the funnel plot of the blood group O in CAD suggested no asymmetry. No obvious evidence of publication bias was present in the comparison of blood group O ([Fig. 6](#f6){ref-type="fig"}).

Discussion {#sec3}
==========

Previous systematic reviews and meta-analysis paid more attention to the relationship between MI and ABO blood group, but the link of ABO blood group system to CAD was rarely evaluated. Besides, almost all available studies principally focused on blood type non-O and O. Hence, the relation between ABO blood group and risk of CAD is worthy to be assessed scientifically and strictly.

Our meta-analysis involved 16 articles (17 studies) covering 225,810 individuals. It was suggested that the risk of CAD in blood group A was mildly increased compared with that in blood group non-A (OR = 1.14). Meanwhile, we investigated the relationship of blood group B, AB compared with non-B, non-AB, respectively, but failed to confirm statistical difference. Moreover, our results indicated that the risk of CAD in blood group O was significantly lower than that in non-O groups (OR = 0.85), which is similar to previous studies[@b8].

To our knowledge, this is the first meta-analysis involved the relationship between the risk of CAD and blood group A and non-A. Several clinical studies have provided direct evidence with different results. Whincup *et al*.[@b28] found that the incidence of ischaemic CAD was higher in those with blood group A than that with blood group non-A (OR = 1.21, 95% CI = 1.01 to 1.46). A study from Wazirali *et al*.[@b29] suggested that blood group A was associated with a substantially increased risk of CAD, which is independent of conventional cardiovascular risk factors. Whereas, another research did not support this association and indicated that the risk of CAD in blood group A was lower than that in other blood groups[@b30]. As we known, meta-analyses provide advance over traditional single studies. That is a reason why we performed a meta-analysis for further evaluating the relation of blood group A to the risk of CAD. In our study, we affirmed blood group A was a risk factor, which is more convincing and reliable. Similar evidence was more robust in the analysis for MI incidence (OR = 1.24).

Our study showed a significantly reduced risk of CAD in individuals with blood group O compared with that with blood group non-O (OR = 0.85, 95% CI = 0.78 to 0.94, p = 0.0008). Evidence was more obvious when we performed an analysis concerning the relationship between ABO blood group and MI (OR = 0.81, 95% CI = 0.69 to 0.94, p = 0.007). In fact, non-O blood group as an independent risk factor was already confirmed in other systematic reviews, too[@b8][@b9][@b10]. Wu *et al*.[@b9] performed a meta-analysis with regard to the relation of ABO blood group to MI and angina in 2008. In their study, taking group O as index, group A and non-O were related to an increase in MI risk (OR = 1.29, 95% CI = 1.16 to 1.45, p \< 0.00001, OR = 1.25, 95% CI = 1.14 to 1.36, p \< 0.00001), while no similar effect was found in the risk of angina. Furthermore, a meta-analysis by Dentali *et al*.[@b8] found that patients with blood group non-O presented a higher prevalence of MI than that with blood group O (OR = 1.28, 95% CI = 1.17 to 1.40, p \< 0.001). Takagi *et al*.[@b10] enrolled 10 studies with a total of 174,945 participants and demonstrated a 14% increase in CAD incidence in individuals with blood group non-O compared to that in blood group O (OR = 1.14, 95% CI = 1.04 to 1.25, p \< 0.006). All in all, the quantitative results from these meta-analyses and our one provided plenty of evidence on the close relationship between risk of CAD and blood group non-O.

The underlying mechanism of the relationship between blood group O and CAD has been clarified. ABO antigen may affect plasma levels of vWF and coagulation factor VIII[@b7], and blood group non-O has the lowest expression of O antigen and relatively higher levels of vWF and factor VIII[@b31]. That blood group O is a potentially important genetic risk factor for bleeding[@b32], which also supports this mechanism theory. Another biologically plausible mechanism involves in glycotransferase-deficient enzyme which renders the ABO blood group to encode O phenotype, resulting in protection of subjects from MI risk[@b33]. The latest study reveals that serum lipid mediates the effect of ABO blood group on CAD. In fact, blood group A is one of the risk factors of CAD mainly due to higher serum total cholesterol (TC) concentration in subjects[@b28]. Our recent study also indicated that there is an association between blood group A and risk of CAD, and around 10.5% of the effect of blood group A on CAD is mediated by TC levels[@b34].

It was mentioned that there were several potential limitations in this study. Firstly, there was certain heterogeneity between various studies. Although we performed subgroup analyses, it was still different among the studies in blood testing methods and diagnostic criteria of CAD, race, life and eating habits, religious beliefs, socio-economic patterns, and concern of the disease, which might result in the heterogeneity. Secondly, we did not find unpublished studies, which may bring about publication bias.

In conclusion, this updated meta-analysis suggests that blood group A and non-O are associated with an increased risk of CAD. However, considering the heterogeneity of included studies and limited number of studies, more rigorous studies with high quality are needed to give high level of evidence to confirm this association.

Methods {#sec4}
=======

This meta-analysis was performed according to the MOOSE group guidelines of observational meta-analyses[@b35].

Data sources and searches
-------------------------

Two reviewers (Zhuo Chen and Sheng-Hua Yang) searched Pubmed and the Cochrane Library from their inception to August 15, 2015 in order to identify all existing literature which assessed the association between ABO blood group and CAD. Mesh vocabulary and free text terms were used for each database with relevant key words such as blood grouping and cross-matching, ABO blood group system, blood group antigens, myocardial ischemia, myocardial infarction, acute coronary syndrome and angina pectoris. Language was limited to English. There was no limitation of country and publication date.

To ensure comprehensive acquisition of studies, the reference lists of the included articles were also manually screened to identify additional eligible studies. Manual searches were also performed on other databases, including Web of Science, and Google Scholar. Furthermore, databases of ongoing trials were also searched: Clinical Trials.gov (<http://clinicaltrials.gov/>) and Current Controlled Trials (<http://www.controlled-trials.com/>).

Study selection
---------------

Studies were independently identified by two reviewers (Zhuo Chen and Sheng-Hua Yang) according to inclusion criteria. Disagreements were resolved through discussion and decided by a third reviewer. Both case-control and cohort studies were included if they met all the following criteria: 1) patients with CAD or even MI; 2) separate data for patients with or without CAD were provided; 3) diseases were objectively diagnosed in line with the diagnosis level at the time; 4) a clear extractable ABO blood group typing. Patients included were regardless of age and race.

Data extraction and quality assessment
--------------------------------------

The retrieved papers were subjected to a rigorous extraction by two authors (Zhuo Chen and Sheng-Hua Yang) independently according to a predesigned form. Disagreements were resolved by consensus or consulted from the third author (Hao Xu). We did not try to contact authors to obtain unpublished data. The methodological quality of studies was assessed using the NOS checklist for observational studies[@b36]. We rated cohort studies a maximum of 4 stars for selection, 2 stars for comparability, and 3 stars for outcome assessment. The maximum score of case-control studies for selection, comparability, and exposure assessment was 4, 2, 3, respectively, too. The highest score is 9, and more stars meant better quality.

Data analysis and synthesis
---------------------------

Revman 5.2 software (The Cochrane Collaboration, Oxford, UK) was used for data analyses. We presented dichotomous data as OR and its 95% CI. Data were assessed by both random and fixed effect models, but only the random effect analyses were reported if the heterogeneity was significant evaluated by the I^2^ statistic which assessed the appropriateness of pooling all studies[@b27]. A funnel plot was used to assess publication bias.

Additional Information
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###### Characteristics of included studies.

  Study year, reference   Type of study                    Total number of subjects                                                                            Age                                                                        Gender                                                                                                                                          Race                               Patients with events                                                                                                                                                    Controls
  ----------------------- -------------------------------- --------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Chen 2014               case-control study               6242                                                                                                64.11 ± 11.42                                                              71.4% are men, 28.6% are women                                                                                                                  Chinese                            consecutive patients undergoing diagnostic or interventional coronary angiography, who were finally diagnosed CAD or MI                                                 consecutive patients undergoing diagnostic or interventional coronary angiography, who were not diagnosed CAD or MI
  Gong 2014               case-control study               3806                                                                                                53.9 ± 9.9                                                                 male (71%)                                                                                                                                      Chinese                            angiographically documented CAD or diagnosed as MI                                                                                                                      the patients without CAD or MI
  Biswas 2013             case-control study               500                                                                                                 cases (mean: 54.71 years) and controls (mean: 54.49 years) (*P* \> 0.05)   females constituted 18.4% of the cases and 16.8% of the controls and males constituted 81.6% of cases and 83.2% of the controls (*P* \> 0.05)   Indian Bengali adults              Patients having typical angina and evidence of ischemia or infarction after electrocardiographic study, tread mill test, stress echo and echocardiographic study        controls comprised the spouses, neighbors, and people from same work place of the patients, with the same sociocultural background, in whom the clinical history, the objective search for signals of CHD, and the electrocardiographic as well as echocardiographic examinations did not suggest the presence of that disease
  Sode 2013               two prospective cohort studies   the Copenhagen general population study(25900) + the Copenhagen city heart study (40097) = 65,997   aged 20--100 years                                                         women (36,562); men (29,439)                                                                                                                    white and of Danish descent        the patients with myocardial infarction (defined as ICD-8 code 410 and ICD-10 codes I21--I22)                                                                           the general population of Copenhagen without diagnoses of MI and IHD
  Franchini 2013          case-control study               6151                                                                                                mean age: 77 years in the CHD group; 34 years in the control group         females: 34.9% in the CHD group; 46.7% in the control group                                                                                     Italians                           the patients with coronary heart disease (CHD)                                                                                                                          the healthy general population
  He 2012                 two prospective cohort studies   \[NHS\]62073                                                                                        aged 30--55 years                                                          women                                                                                                                                           American (different ethnicities)   incident cases of CAD                                                                                                                                                   patients in the same cohort who did not occur coronary heart disease
                                                           \[HPFS\]27428                                                                                       aged 40 to 75 years                                                        male                                                                                                                                            American (different ethnicities)   incident cases of CAD                                                                                                                                                   patients in the same cohort who did not occur coronary heart disease
  Lee 2012                case-control study               265                                                                                                 men younger than 45 years and women younger than 55 years                  52.1% are men, 47.9% are women                                                                                                                  Chinese                            subjects who underwent coronary angiography with documented CAD                                                                                                         subjects without angiographically demonstrable lesions served as controls
  Sari 2008               case-control study               679                                                                                                 mean age 56.7 ± 11.7 in case, mean age 58.1 ± 12.2 in control              80.3% men in patients, 82.7% men in control                                                                                                     Turkish                            patients with acute ST elevation MI                                                                                                                                     subjects without known CAD
  Tanis 2006              case-control study               826                                                                                                 between 18 and 49 yr of age                                                women                                                                                                                                           Netherlands                        the patients suffered from MI                                                                                                                                           women contacted by random-digit dialing, stratified for age, index year for MI, and area of residence
  Amirzadegan 2006        retrospective cohort study       2026                                                                                                a mean age of 59 years                                                     1512 males (75.4%) and 494 females (24.6%)                                                                                                      Iranian                            the patients with premature CAD defined as development of CAD under 45 years old                                                                                        the patients without premature CAD defined as development of CAD under 45 years old
  Nydegger 2003           case-control study               266                                                                                                 median age 57.0 years; range 32--72 years                                  87.6% men in patients, 88.8% men in controls                                                                                                    Caucasian                          survivors of an acute myocardial infarction that had occurred at least 2 months before inclusion in the study                                                           healthy Caucasian without a history of thromboembolic events or tendency to bleed, were frequency-matched to the cases by age (SD 5 years) and sex
  Platt 1985              retrospective cohort study       450                                                                                                 66/450 (age \< 65 yr) 384/450 (age \>= 65 years)                           139/450 (male)                                                                                                                                  German                             the patients with cardiac infarction                                                                                                                                    sample of the German population
  Saha 1973               case-control study               26186                                                                                               age \>= 20 years                                                           NR                                                                                                                                              Chinese Malays Indians             the patients with myocardial Infarction                                                                                                                                 the healthy individuals (matched for race and sex)
  Allan 1968              case-control study               7294                                                                                                NR                                                                         the ABO blood group distribution is almost exactly the same for men and women.                                                                  British                            the patients with myocardial infarction                                                                                                                                 consecutively-registered blood donors
  Gjørup 1963             case-control study               15,150                                                                                              NR                                                                         610/846 (Male) 236/846 (women) in case group                                                                                                    Danes                              the patients with coronary occlusion                                                                                                                                    blood donors from the same area
  Pell 1961               retrospective cohort study       471                                                                                                 from 17 through 64 years                                                   NR                                                                                                                                              American                           the medical records of the 438 employees (coronary patients) who had a first coronary attack of coronary thrombosis and or myocardial infarction during 1957 and 1958   the records of the 438 matched controls (the controls were drawn at random from a complete listing of company employees with the aid of a table of random numbers, and were matched to each case in our series by age, sex, payroll classification, and geographical location) were reviewed to compare the occurrence of certain chronic diseases in the two groups

NR: not report.

CAD: coronary artery disease.

MI: myocardial infarction.

###### Blood types distribution and outcome definitions of included studies.

  Study year, reference          A, non-A                B, non-B              AB, non-AB               O, non-O         Outcome definitions
  ----------------------- ----------------------- ---------------------- ---------------------- ------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Chen 2014                1227/1692, 3150/4550    1142/1611, 3235/4631    323/451, 4054/5791     1685/2488, 2692/3754   CAD: Significant CAD indicated by \>50% stenosis in ≥1 coronary artery in angiography.
  Gong 2014                 909/1026, 2434/2780    1106/1241, 2237/2565    367/410, 2976/3396     961/1129, 2382/2677    significant angiographically documented CAD as having \>50% diameters stenosis in ≥1 major coronary artery
  Biswas 2013                 60/114, 190/386        77/158, 173/342         17/78, 233/422         96/150, 154/350      CAD: typical angina and evidence of ischemia or infarction
  Sode 2013                                                                                      1035/25900, 1673/40087  myocardial infarction was defined as ICD-8 code 410 and ICD-10 codes I21-I22.
  Franchini 2013            856/2604, 1023/3547     179/617, 1700/5534     75/261, 1804/5890      769/2669, 1110/3482    coronary heart disease (CHD)
  He 2012 \[NHS\]          723/22358, 1332/39715   296/8263, 1759/53810   195/4812, 1860/57261   841/26640, 1214/35433   Incident cases of CAD (non-fatal MI or fatal CHD): A physician unaware of the self-reported risk factor status verified the report of MI through review of medical/hospital records by using the World Health Organization criteria of symptoms and either typical ECG changes or elevated cardiac enzymes. 26 Fatal CAD was confirmed by medical records or autopsy reports, or by CAD listed as the cause of death on the death certificate and there was evidence of previous CHD in the records.
  He 2012 \[HPFS\]         737/10213, 1272/17215   246/3365, 1769/24063   199/2049, 1816/25379   833/11801, 1182/15627    
  Lee 2012                     54/85, 82/180          36/71, 100/194         5/13, 131/252           41/96, 95/169       presence of CAD was defined as \>50% stenosis in at least 1 major coronary branch, on coronary angiography.
  Sari 2008                  205/295, 271/384        72/103, 404/576         51/76, 425/603         148/205, 328/474     MI: based on typical chest pain for at least 30 min, ST elevation of 0.2 mV or more in at least two contiguous electrocardiogram leads and confirmatory elevations of at least two-fold in serum creatine kinase-MB isoenzyme levels
  Tanis 2006                                                                                        66/359, 134/467      acute MI
  Amirzadegan 2006           60/650, 148/1376        59/503, 149/1523       8/153, 200/1873         8/153, 127/1306      premature CAD defined as development of CAD under 45 years old
  Nydegger 2003               87/133, 90/133          21/25, 156/241         8/10, 169/256           61/98, 116/168      acute myocardial infarction
  Platt 1985                  137/253, 56/197         9/38, 184/412          5/14, 188/436          42/145, 151/305      cardiac infarction: NR
  Saha 1973                 119/6506, 344/19680    120/7210, 343/18976     45/1598, 418/24588     179/10872, 284/15314   myocardial Infarction: all cases of myocardial infarction as confirmed by clinical, electrocardiographic, and biochemical investigations
  Allan 1968                 92/2607, 110/4687      774/795, 178/6499       4/245, 198/7049        82/3647, 120/3647     myocardial Infarction: unequivocal electrocardiographic evidence of recent infarction, or if appropriate rises in serum transaminase levels occurred where myocardial changes were masked, as, for example, by a bundle-branch-block pattern
  Gjørup 1963               372/6671, 474/8479      93/1650, 753/13500     36/680, 810/14470       345/6149, 501/9001    coronary occlusion: typical ECG abnormalities combined with characteristic pains
  Pell 1961                   98/192, 128/279         21/46, 205/425         6/13, 220/458          101/220, 125/251     MI:NR

NR: not report.

CAD: coronary artery disease.

MI: myocardial infarction.

###### Newcastle-Ottawa Scale table.

  Study reference         Selection   Comparability   Measurement   Total
  ---------------------- ----------- --------------- ------------- -------
  Case-control studies                                             
   Chen 2014                  4             1              2          7
   Gong 2014                  2             1              3          6
   Biswas 2013                4             1              3          8
   Franchini M 2013           2             1              2          5
   Lee 2012                   4             1              2          7
   Sari 2008                  3             2              3          8
   Tanis 2006                 2             1              2          5
   Nydegger 2003              1             0              1          2
   Platt 1985                 2             0              1          3
   Jick 1978                  3             1              2          6
   SAHA 1973                  2             1              2          5
   ALLAN 1968                 3             1              2          6
   Gjørup 1963                3             1              1          5
   Pell 1961                  2             1              0          3
  cohort studies                                                   
   Sode 2013                  3             2              2          7
   He 2012 \[NHS\]            3             2              3          8
   He 2012 \[HPFS\]           3             2              3          8

[^1]: These authors contributed equally to this work.
